1-3 of 3
Mihaela Zlei
Close
Sort by
Journal Articles

A Novel 10-Fluorochrome Multiparameter Flow Cytometry (MFC) Panel for Precise Plasma Cell (PC) and MRD Assessment in Clinical Routine of Multiple Myeloma (MM) Patients and throughout the Disease Course

Veronika Riebl, Sandra M. Woerner, Dagmar Wider, Marie Follo, Stefan J. Mueller, Cornelius Miething, Mihaela Zlei, Justus Duyster, MD, Ralph Wäsch, MD, Monika Engelhardt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1789.
https://doi.org/10.1182/blood-2019-124680
Published: 2019
Journal Articles

Minimal Residual Disease (MRD) Analysis Using Multiparametric Flow Cytometry (MFC) and Identification of Differences in Subpopulations Using Next Generation Sequencing (NGS) in the Bone Marrow (BM) of Multiple Myeloma (MM) Patients (pts)

Sandra M. Dold, MSc, BSc, Veronika Riebl, Dagmar Wider, Marie Follo, PhD, Stefan J. Mueller, Ingrid Bartsch, Milena Pantic, PhD, Cornelius Miething, MD, Chrissoula Kiote-Schmidt, K. Martin Kortüm, MD, Mihaela Zlei, Abdel Kareem Azab, PhD, Mascha Binder, MD, Justyna Rawluk, Justus Duyster, Prof., Robert Zeiser, MD, Ralph Wäsch, MD, Monika Engelhardt, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3222.
https://doi.org/10.1182/blood-2018-99-112489
Published: 2018
Journal Articles

Assessment of the Culture Requirements for Optimal In Vitro Growth and Survival of Multiple Myeloma (MM) Cells.

Mihaela Zlei, PhD, Sabine Egert, Christine Bayer, Dagmar Wider, Julia Schüler, PhD, Monika Engelhardt, MD
Journal: Blood
Blood (2006) 108 (11): 3513.
https://doi.org/10.1182/blood.V108.11.3513.3513
Published: 2006